Barclays Maintains an 'Overweight' on Marathon Petroleum (MPC); EPS Revision
Get Alerts MPC Hot Sheet
Price: $199.65 +0.71%
Rating Summary:
19 Buy, 7 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
19 Buy, 7 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Marathon Petroleum (NYSE: MPC), PT $51.
Barclays analyst says, "We fine-tune our EPS estimates for MPC following the company's release of the Investor Relations packet as well as final mark-to-market on our commodity price deck...We lower our 2Q11 EPS estimate to $2.46 from $2.54, while raising our 3Q11 and 4Q11 EPS estimates to $1.78 and $1.77 from $1.76 and $1.72, respectively...We keep our 2011 and 2012 EPS estimates unchanged at $7.50 and $5.45, respectively."
For more ratings news on Marathon Petroleum click here and for the rating history of Marathon Petroleum click here.
Shares of Marathon Petroleum closed at $39.12 yesterday.
Barclays analyst says, "We fine-tune our EPS estimates for MPC following the company's release of the Investor Relations packet as well as final mark-to-market on our commodity price deck...We lower our 2Q11 EPS estimate to $2.46 from $2.54, while raising our 3Q11 and 4Q11 EPS estimates to $1.78 and $1.77 from $1.76 and $1.72, respectively...We keep our 2011 and 2012 EPS estimates unchanged at $7.50 and $5.45, respectively."
For more ratings news on Marathon Petroleum click here and for the rating history of Marathon Petroleum click here.
Shares of Marathon Petroleum closed at $39.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FI) PT Raised to $175 at TD Cowen
- Quest Diagnostics (DGX) PT Raised to $145 at Evercore ISI
- Costco Wholesale (COST) PT Raised to $710 at Citi
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!